Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence. Issue 5 (May 2022)

• Record Type: Journal Article
• Authors: Macbeth, F.; Treasure, T.
• Is Part Of: Clinical oncology. Volume 34:Issue 5(2022)
• Page Start: 313
• Page End: 317
• Publication Date: 2022-05
• Subjects: Lung metastases -- Metastases -- Stereotactic radiotherapy; Oncology -- Periodicals; Tumors -- Periodicals; Cancer -- Treatment -- Periodicals; Radiotherapy -- Periodicals; Neoplasms -- Periodicals; Cancer -- Radiotherapy; Cancer -- Treatment; Oncology; Medical radiology; Radiotherapy; Tumors; Electronic journals; Periodicals; 616.994
• DOI: 10.1016/j.clon.2022.02.008
• Languages: English
• ISSNs: 0936-6555

Abstract

Abstract: The prospective study Pulmonary Metastasectomy in Colorectal Cancer (N = 391) showed that expert selection was made on known prognostic features – number of metastases, tumour markers, liver involvement, interval – and patient performance and outcomes replicated follow-up studies. In the nested controlled trial all factors were well balanced and no survival difference remained.